Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,331,768
  • Shares Outstanding, K 43,117
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,990 K
  • EBIT $ -142 M
  • EBITDA $ -141 M
  • 60-Month Beta -1.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.18

Options Overview Details

View History
  • Implied Volatility 64.88% ( +4.56%)
  • Historical Volatility 43.52%
  • IV Percentile 26%
  • IV Rank 20.58%
  • IV High 145.78% on 03/05/24
  • IV Low 43.92% on 10/15/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 1,374
  • Volume Avg (30-Day) 1,738
  • Put/Call OI Ratio 1.87
  • Today's Open Interest 81,025
  • Open Int (30-Day) 69,341

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.75
  • Number of Estimates 4
  • High Estimate -0.58
  • Low Estimate -0.99
  • Prior Year -0.33
  • Growth Rate Est. (year over year) -127.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.92 +4.15%
on 10/24/24
59.75 -9.50%
on 11/11/24
+0.22 (+0.41%)
since 10/14/24
3-Month
43.51 +24.29%
on 08/23/24
59.75 -9.50%
on 11/11/24
+5.20 (+10.64%)
since 08/14/24
52-Week
21.75 +148.64%
on 11/15/23
59.75 -9.50%
on 11/11/24
+31.49 (+139.40%)
since 11/14/23

Most Recent Stories

More News
Soleno Therapeutics to Present DCCR Clinical Data for Prader-Willi Syndrome at 62nd Annual ESPE Meeting

Soleno Therapeutics will present DCCR clinical data for Prader-Willi syndrome at the upcoming ESPE Meeting in Liverpool.Quiver AI SummarySoleno Therapeutics, Inc. announced that it will present data from...

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

SLNO : 54.08 (-2.87%)
Soleno Therapeutics to Participate in Upcoming November Investor Conferences

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.

SLNO : 54.08 (-2.87%)
Why Soleno Therapeutics Stock Blasted 9% Higher Today

The company's Prader-Willi treatment inched closer to FDA approval.

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome

SLNO : 54.08 (-2.87%)
3 Top Small-Cap Tech Picks for Investors This Month

Wall Street believes these three small companies have significant upside potential.

AMZN : 210.00 (-0.70%)
MSFT : 423.34 (-0.83%)
NVDA : 145.18 (-1.08%)
CHPT : 1.1100 (-0.89%)
$SPX : 5,949.17 (-0.60%)
VRDN : 21.30 (-1.57%)
SLNO : 54.08 (-2.87%)
Why Soleno Therapeutics Stock Is Skyrocketing Today

The clinical-stage biotech company received great news from the FDA.

SLNO : 54.08 (-2.87%)
Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

SLNO : 54.08 (-2.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 57.92
2nd Resistance Point 56.97
1st Resistance Point 55.52
Last Price 54.08
1st Support Level 53.13
2nd Support Level 52.18
3rd Support Level 50.73

See More

52-Week High 59.75
Last Price 54.08
Fibonacci 61.8% 45.24
Fibonacci 50% 40.75
Fibonacci 38.2% 36.27
52-Week Low 21.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar